Next generation of antimicrobials must be antibiofilms

Thierry Bernardi


Dr Thierry Bernardi

CEO – Pharm. D


Thierry is the founder of BioFilm Pharma in 2017, after the creation of BioFilm Control to develop his disruptive invention to test biofilms (BioFilm Ring Test®), now standardized and automatized (ISO13485), driving to release on the market the first Diagnostic test “biofilm” (Antibiofilmogram®, CE marking for 2018), the first able to detect the side effect “antibiotic inducing biofilm”. Thierry won 2 Oseo Innovation awards (ex-bpifrance), and drove a granted project (FUI BIOFILM) involving 5 hospitals and 2 industrial partners.

He has co-authored 20 peer reviewed publications and 10 patented applications, mainly using the BioFilm Ring Test® technology.

Prior founding BioFilm Control, he held several technical, general management and business development positions in multinational companies and start-up (Perkin Elmer, Applied BioSystems, Aurigene BioSystems, GeneSystems…).

In 1991, he earned his Pharm.D from the University of Montpellier (France), following in parallel a full cursus in Science until a Master Biology-Health.